AXL and SHC1 confer crizotinib resistance in patient-derived xenograft model of ALK-driven lung cancer

Bibliographic Details
Title: AXL and SHC1 confer crizotinib resistance in patient-derived xenograft model of ALK-driven lung cancer
Authors: Hu, Yerong 1, Zhou, Yangzhao 1, Liu, Wenliang 2, Chen, Mingjiu 2, Hao, Yimei 3, Qu, Guojun 4, Xia, Zhenkun 2, Zhou, Xinmin 1, Li, Yu 4, 5, 6, ∗, Tan, Ling 1, 6, 7, ∗∗
Source: In iScience 20 September 2024 27(9)
Database: ScienceDirect
More Details
ISSN:25890042
DOI:10.1016/j.isci.2024.110846
Published in:iScience
Language:English